If you are planning to get a flu shot or COVID booster this fall, there is a bureaucratic fight happening in Washington right now that could determine whether your insurance covers it.
HHS Secretary Robert F. Kennedy Jr. has published a newly rewritten charter for the CDC's Advisory Committee on Immunization Practices (ACIP) — the federal body whose recommendations determine which vaccines are covered without a copay by private insurance, purchased free for low-income children through the Vaccines for Children program, and used by Medicare and Medicaid to set coverage policy. The new charter, dated May 14, 2026 and only recently made public, is the second rewrite of the committee's governing document since March, and it arrives at a moment when the committee has had no functioning quorum to make any official recommendations at all.
Why This Matters
ACIP's recommendations are not merely advisory in a symbolic sense. Once accepted by the CDC director, they directly determine which vaccines insurance companies must cover without cost-sharing under the Affordable Care Act, which vaccines are purchased and distributed free to low-income children through the Vaccines for Children program, and which vaccines Medicare and Medicaid will reimburse. States and school districts also rely on ACIP recommendations to set their own vaccination requirements.
According to CIDRAP's ongoing tracking of the situation, on May 28, 2026, the FDA's own vaccine advisory committee (VRBPAC) voted to recommend that the fall 2026–2027 COVID-19 vaccine target the XFG strain, and the FDA adopted that recommendation the following day. Normally, the next step is for ACIP to make the official insurance-determining recommendation on who should receive the vaccine and how costs should be covered. With no functioning ACIP, that step has not happened, and there is currently no clear mechanism for when or how it will.
What We Know So Far
The crisis traces back to Kennedy's actions shortly after taking office. Within months of becoming HHS Secretary, Kennedy fired all 17 previous ACIP members and replaced them with a smaller panel that included people with documented histories of vaccine skepticism. In a preliminary ruling on March 16, 2026, U.S. District Judge Brian Murphy in Boston found that most of Kennedy's appointed ACIP members were "distinctly unqualified" — noting that only six of the 15 members had any meaningful experience in vaccines, in violation of the charter's own requirements at the time. Murphy's ruling stayed the committee's operations, leaving it without a working quorum.
Since that ruling, HHS has rewritten the ACIP charter twice — once in April and again in May — and issued an executive order in late May, all while the underlying legal challenge from the American Academy of Pediatrics and other medical organizations remains active and unresolved.
The most recent charter version, dated May 14, significantly broadens both committee membership criteria and the scope of the committee's work. Where the prior charter required members to have specific expertise in vaccine use, vaccine research, or vaccine safety and efficacy, the new version broadens acceptable expertise to include fields like biostatistics and toxicology — categories that would qualify several of Kennedy's previously "unqualified" appointees.
What the New Charter Actually Changes
The substantive changes go beyond membership qualifications. According to STAT News' detailed reporting, the revised charter redirects the committee's core mission. Charlotte Moser, a member of the former ACIP fired by Kennedy in June 2025, summarized the shift directly: "The revised text suggests that rather than focusing on how to effectively and safely use vaccines, the committee should be comparing vaccines with 'other preventive measures' and advising on 'gaps and limitations in evidence.'"
According to CNN's review of the charter's contents, the document puts new emphasis on "identifying gaps in vaccine safety research, including adverse effects following vaccination," directs the committee to consider the "cumulative effects" of giving all recommended childhood vaccines together, and specifically tasks ACIP with scrutinizing "novel vaccine platforms such as mRNA vaccines" and reviewing vaccine schedules used by other countries.
The charter also adds several new non-voting liaison member organizations, including the Independent Medical Alliance, Physicians for Informed Consent, and the Association of American Physicians and Surgeons — groups that, as CNN reported, maintain that vaccine risks are underreported and that vaccine benefits may not outweigh their harms.
What Doctors and Experts Say
Paul Offit, MD, a pediatrician and vaccine expert at Children's Hospital of Philadelphia, characterized the rewrite directly: "RFK Jr. is trying to retrofit the charter to make it so that the people that he brought in qualify. So therefore, he's trying to make it so that we don't have an expertise that can best advise us." Offit added more broadly: "What he is doing is incredibly dangerous. I just feel like we're slowly approaching this cliff and about to fall off in slow motion."
Richard Hughes IV, the attorney representing the American Academy of Pediatrics and other medical associations in the ongoing lawsuit against Kennedy, said the new charter "is just an attempt to make things look better on paper" and "does not cure the problems we are challenging." He separately noted that the new focus on adverse events "is especially concerning, as it appears to foreground vaccine harms in a way that could further reorient ACIP's mandate."
HHS spokeswoman Emily Hilliard offered a different characterization, stating: "The updated ACIP charter clarifies the committee's advisory role and responsibilities to improve transparency, accountability, and efficiency, while preserving its longstanding mission to review scientific evidence."
The Practical Coverage Problem Building for Fall
The most concrete, immediate consequence of the ongoing quorum crisis is the absence of a finalized recommendation for fall 2026 respiratory virus vaccines. As CIDRAP's update bluntly puts it: "There is still no quorum, and that's a gap that both sides agree needs to be filled. After all, fall respiratory vaccine recommendations have to come from somewhere."
Federal procurement records reviewed by CIDRAP show that in early June 2026, the CDC invested roughly $1.24 billion in COVID-19 vaccine contracts with Pfizer and Sanofi — suggesting the federal government is proceeding with vaccine procurement even without a finalized ACIP recommendation. Kennedy has disputed characterizing these as completed purchases, describing them instead as indefinite delivery agreements that "ensure availability if needed."
Without an ACIP recommendation specifically establishing who should receive the vaccine and on what schedule, the formal legal mechanism that obligates insurers to cover the vaccine without cost-sharing remains unresolved — creating uncertainty for roughly 90 million Americans whose vaccine coverage, through Medicare, Medicaid, or the Vaccines for Children program, depends on that recommendation being finalized.
Who Is Most Affected?
- Medicare and Medicaid beneficiaries whose vaccine coverage depends on finalized ACIP recommendations
- Low-income families with children enrolled in the Vaccines for Children program, which uses ACIP recommendations to determine free vaccine distribution
- Privately insured Americans, whose ACA-guaranteed no-cost-sharing vaccine coverage is tied to ACIP recommendations
- Pediatricians and primary care physicians, who rely on ACIP's vaccine schedule to guide patient care and who currently lack updated official guidance for fall 2026
- More than 130 medical organizations that have formally objected to the charter changes and the ongoing absence of a functioning committee
What the Evidence Shows — and What It Does Not
The sequence of events — the March court ruling finding ACIP members unqualified, the subsequent charter rewrites, and the continued absence of a quorum — is well documented through court filings, HHS publications, and consistent reporting across multiple outlets. The concrete consequence — no finalized fall 2026 vaccine recommendation as of late June — is also documented through CIDRAP's direct tracking of CDC procurement and FDA committee actions.
What remains legally and practically uncertain is how the situation will be resolved before fall vaccination season begins. The underlying lawsuit (American Academy of Pediatrics v. Kennedy) remains active, with the two sides disputing what materials will be considered confidential in the case. An expedited appeal was requested 88 days after the original March stay was issued, indicating the legal process itself has moved more slowly than the practical urgency of the fall vaccination timeline requires.
What You Can Do Now
- Continue planning to get your annual flu shot and any recommended COVID booster this fall — the absence of a finalized ACIP recommendation does not mean these vaccines are unavailable or unsafe, only that the formal coverage-determining mechanism is currently unresolved.
- If you have private insurance, contact your insurer directly closer to fall to confirm coverage terms for seasonal vaccines, given the ongoing uncertainty.
- If your child relies on the Vaccines for Children program, ask your pediatrician's office about current guidance, as providers are closely monitoring this situation.
- Follow updates from your professional medical association if you are a clinician, as more than 130 medical organizations are actively tracking and responding to this situation.
- Monitor CIDRAP's ongoing coverage at cidrap.umn.edu for the most current, detailed tracking of the ACIP quorum situation as it develops.
What Happens Next
The American Academy of Pediatrics v. Kennedy lawsuit remains active, with an expedited appeal request now pending before the court. Fall 2026 vaccine recommendations need to be finalized in the coming weeks to align with typical September vaccination timelines. MedicalDaily will report on any resolution of the quorum crisis, any new ACIP meeting or vote, and any clarification of fall 2026 vaccine insurance coverage as developments occur.
The Bottom Line
A federal vaccine advisory committee with no functioning quorum since March 2026, two charter rewrites since then, and an active federal lawsuit have combined to leave fall 2026 flu and COVID vaccine insurance coverage determinations in genuine uncertainty — a concrete, practical consequence for roughly 90 million Americans on Medicare, Medicaid, or in the Vaccines for Children program, and for privately insured Americans whose no-cost vaccine coverage depends on this committee's recommendations. This is not an abstract bureaucratic dispute; it is a live question about whether your fall vaccination will be covered, and it remains unresolved.
